You are here: Industry Insights > NHS

News List

NICE bars obesity pill from routine NHS use pharmatimes
August 01, 2017
Cost regulators for NHS treatments in England and Wales are standing by their position that Orexigen’s weight loss pill Mysimba can not be recommended as a cost-effective treatment option.
Final NHS nod for Allergan’s Ozurdex, AbbVie’s Humira in uveitis pharmatimes
July 28, 2017
Cost regulators for NHS treatments in England and Wales have deemed AbbVie’s Humira and Allergan’s Ozurdex clinically and cost effective for treating adults with...
NICE backs Roche’s Gazyvaro for follicular lymphoma pharmatimes
July 27, 2017
The National Institute for Health and Care Excellence has issued final draft guidance recommending that use of Roche’s Gazyvaro to treat follicular lymphoma be funded for NHS use via the Cancer Drug Fund.
Further evidence of NHS recruitment crisis as vacancies skyrocket pharmafile
July 26, 2017
Data released by NHS Digital rings a very worn bell regarding levels of staff employed and recruited the NHS, as it points to a further drop in applicant numbers and vacancies.
NHS should pay for medicines based on outcomes, argues Novartis-backed report pharmaphorum
July 25, 2017
A new report from the Social Market Foundation think tank argues that the UK’s National Health Service should switch to paying for medicines based on patient outcomes.
NICE approves new tolerable drug carflizomib for multiple myeloma patients on NHS pharmaceutical-technology
July 25, 2017
UK’s National Institute for Health and Care Excellence (NICE) has approved Amgen’s new anti-cancer treatment carflizomib for multiple myeloma patients on the National Health Service (NHS).
NHS England consults on blocking ‘wasteful’ prescriptions pharmatimes
July 25, 2017
NHS England has unveiled detailed proposals of how prescriptions for “ineffective, over-priced and low value treatments” will be cut in order to shave millions off of the NHS’ drugs bill.
NHS England takes tough stance on homeopathy pharmafile
July 25, 2017
Homeopathy is one of the most controversial subjects within the healthcare system and NHS England has outlined its stance by proposing cutting funding to the medicine.
Cost-cutting not the way to drive value for the NHS, finds independent committee pharmafile
July 20, 2017
An independent steering committee has compiled a report looking at how more can be delivered from the NHS budget, without necessitating cuts to funding within the system.
Google’s DeepMind app deal with NHS brought into question pharmafile
July 06, 2017
DeepMind’s deal with the NHS to develop an app that is able to detect possible kidney damage involved 1.6 million patients’ data has proved controversial. This is due to the fact that those whose data were involved did not know for what purpose they were

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page